PER 1.35% 7.5¢ percheron therapeutics limited

just called anp, page-18

  1. 1,360 Posts.
    lightbulb Created with Sketch. 2158
    To add to my last post has anyone also forgot that yes ANP may move forward with phase 2a with acromegaly but that this pharma could be looking to partner off ATL1103 for other applications like cancer or diabetic retinopathy. ANP could get an up front cash payment for these applications with milestone and royalty payments to add but be able to use these payments to develop ATL1103 for acromegaly which would be a real win for shareholders.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
0.001(1.35%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.7¢ 7.8¢ 7.4¢ $24.63K 325.4K

Buyers (Bids)

No. Vol. Price($)
2 142779 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8181 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.